Association of rs2072183 SNP and serum lipid levels in the Mulao and Han populations

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Miao, Lin ^a   Yin, Rui Xing ^a   Hu, Xi Jiang ^a   Wu, Dong Feng ^a   Cao, Xiao Li ^a   Li, Qing ^a   Yan, Ting Ting ^a   Aung, Lynn Htet Htet ^a   Wu, Jin Zhen ^a   Lin, Wei Xiong ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; GENOMIC DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHINESE; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPIDS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84861561830     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-61     Document Type: Article

References (62)

1. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB, JAMA 1986 256 2835 2838 10.1001/jama.1986. 03380200073024 3773200 (Pubitemid 17178361)
2. Prediction of coronary heart disease using risk factor categories. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB, Circulation 1998 97 1837 1847 10.1161/01.CIR.97.18.1837 9603539 (Pubitemid 28213628)
3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group, N Engl J Med 1998 339 1349 1357 9841303
4. Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial. Horiuchi H, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H, J-LIT Study Group, J Am Geriatr Soc 2004 52 1981 1987 10.1111/j.1532-5415.2004. 52552.x 15571531 (Pubitemid 41725012)
5. Apoproteins B and A-I and coronary artery disease in humans. Brunzell JD, Sniderman AD, Albers JJ, Kwiterovich PO, Arteriosclerosis 1984 4 79 83 10.1161/01.ATV.4.2.79 6422918 (Pubitemid 14152884)
6. Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks. Onat A, Ozhan H, Can G, Hergenç G, Karabulut A, Albayrak S, Anadolu Kardiyol Derg 2007 7 128 133 17513206 (Pubitemid 46881943)
7. Lipids and risk of coronary heart disease. The Framingham Study. Castelli WP, Anderson K, Wilson PW, Levy D, Ann Epidemiol 1992 2 23 28 10.1016/1047-2797(92)90033-M 1342260
8. Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy. Ballantyne CM, Herd JA, Ferlic LL, Dunn JK, Farmer JA, Jones PH, Schein JR, Gotto AM, Circulation 1999 99 736 743 10.1161/01.CIR.99.6.736 9989957 (Pubitemid 29083012)
9. Primary prevention of coronary heart disease: role of cholesterol control in the United States. Grundy SM, J Intern Med 1997 241 295 306 10.1046/j.1365-2796.1997.110123000.x 9159601 (Pubitemid 27223995)
10. Cholesterol reduction yields clinical benefit: Impact of Statin Trials. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD, Circulation 1998 97 946 952 10.1161/01.CIR.97.10.946 9529261 (Pubitemid 28125465)
11. Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter. Davis HR, Altmann SW, Biochim Biophys Acta 2009 1791 679 683 10.1016/j.bbalip.2009.01. 002 19272334
12. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. Bosner MS, Lange LG, Stenson WF, Ostlund RE, J Lipid Res 1999 40 302 308 9925660 (Pubitemid 29069805)
13. NPC1L1 and cholesterol transport. Betters JL, Yu L, FEBS Lett 2010 584 2740 2747 10.1016/j.febslet.2010.03.030 20307540
14. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Cohen JC, Pertsemlidis A, Fahmi S, Esmail S, Vega GL, Grundy SM, Hobbs HH, Proc Natl Acad Sci USA 2006 103 1810 1815 10.1073/pnas.0508483103 16449388 (Pubitemid 43228775)
15. Genetic and environmental influences on serum lipid levels in twins. Heller DA, de Faire U, Pedersen NL, Dahlén G, McClearn GE, N Engl J Med 1993 328 1150 1156 10.1056/NEJM199304223281603 8455681 (Pubitemid 23105752)
16. Genetics of atherosclerosis. Lusis AJ, Mar R, Pajukanta P, Annu Rev Genomics Hum Genet 2004 5 189 218 10.1146/annurev.genom.5.061903.175930 15485348 (Pubitemid 39362746)
17. Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption. Gylling H, Miettinen TA, J Lipid Res 2002 43 1472 1476 10.1194/jlr.M200155-JLR200 12235179
18. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations. Yijiang Z, Ruixing Y, Yiyang L, Yaju D, Shangling P, Weixiong L, Dezhai Y, J Investig Med 2008 56 847 857 18667902
19. ABCG5/G8 polymorphisms and markers of cholesterol metabolism: systematic review and meta-analysis. Jakulj L, Vissers MN, Tanck MW, Hutten BA, Stellaard F, Kastelein JJ, Dallinga-Thie GM, J Lipid Res 2010 51 3016 3023 10.1194/jlr.M008128 20581104
20. The g.-762T≥C polymorphism of the NPC1L1 gene is common in Chinese and contributes to a higher promoter activity and higher serum cholesterol levels. Chen CW, Hwang JJ, Tsai CT, Su YN, Hsueh CH, Shen MJ, J Hum Genet 2009 54 242 247 10.1038/jhg.2009.18 19265861
21. Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Altmann SW, Davis HR, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP, Science 2004 303 1201 1204 10.1126/science.1093131 14976318 (Pubitemid 38233587)
22. Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. Davis HR, Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, Yao X, Iyer SP, Lam MH, Lund EG, Detmers PA, Graziano MP, Altmann SW, J Biol Chem 2004 279 33586 33592 10.1074/jbc.M405817200 15173162 (Pubitemid 39063007)
23. Localization and role of NPC1L1 in cholesterol absorption in human intestine. Sané AT, Sinnett D, Delvin E, Bendayan M, Marcil V, Ménard D, Beaulieu JF, Levy E, J Lipid Res 2006 47 2112 2120 10.1194/jlr.M600174-JLR200 16829661 (Pubitemid 44936122)
24. Genetic variation in ABC G5/G8 and NPC1L1 impact cholesterol response to plant sterols in hypercholesterolemic men. Zhao HL, Houweling AH, Vanstone CA, Jew S, Trautwein EA, Duchateau GS, Jones PJ, Lipids 2008 43 1155 1164 10.1007/s11745-008-3241-y 18850127
25. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR, Dean DC, Detmers PA, Graziano MP, Hughes M, Macintyre DE, Ogawa A, O'neill KA, Iyer SP, Shevell DE, Smith MM, Tang YS, Makarewicz AM, Ujjainwalla F, Altmann SW, Chapman KT, Thornberry NA, Proc Natl Acad Sci USA 2005 102 8132 8137 10.1073/pnas.0500269102 15928087 (Pubitemid 40800055)
26. Intestinal lipid absorption. Iqbal J, Hussain MM, Am J Physiol Endocrinol Metab 2009 296 1183 1194 10.1152/ajpendo.90899.2008
27. Development and physiological regulation of intestinal lipid absorption. III. Intestinal transporters and cholesterol absorption. Hui DY, Labonté ED, Howles PN, Am J Physiol Gastrointest Liver Physiol 2008 294 839 843 10.1152/ajpgi.00061.2008 (Pubitemid 351520052)
28. Niemann-Pick C1-like 1 overexpression facilitates ezetimibe-sensitive cholesterol and beta-sitosterol uptake in CaCo-2 cells. Yamanashi Y, Takada T, Suzuki H, Pharmacol Exp Ther 2007 320 559 564 (Pubitemid 46147934)
29. Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Investigators: Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly. Polisecki E, Peter I, Simon JS, Hegele RA, Robertson M, Ford I, Shepherd J, Packard C, Jukema JW, de Craen AJ, Westendorp RG, Buckley BM, Schaefer EJ, J Lipid Res 2010 51 1201 1207 10.1194/jlr.P001172 19752398
30. A SNP of NPC1L1 affects cholesterol absorption in Japanese. Maeda T, Honda A, Ishikawa T, Kinoshita M, Mashimo Y, Takeoka Y, Yasuda D, Kusano J, Tsukamoto K, Matsuzaki Y, Teramoto T, J Atheroscler Thromb 2010 17 356 360 10.5551/jat.2451 20379057
31. In-vitro characterization of the six clustered variants of NPC1L1 observed in cholesterol low absorbers. Yamanashi Y, Takada T, Suzuki H, Pharmacogenetics Genom 2009 19 884 892 10.1097/FPC.0b013e3283327925
32. Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment. Simon JS, Karnoub MC, Devlin DJ, Arreaza MG, Qiu P, Monks SA, Severino ME, Deutsch P, Palmisano J, Sachs AB, Bayne ML, Plump AS, Schadt EE, Genomics 2005 86 648 656 10.1016/j.ygeno.2005.08.007 16297596 (Pubitemid 41752945)
33. NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe. Hegele RA, Guy J, Ban MR, Wang J, Lipids Health Dis 2005 4 16 10.1186/1476-511X-4-16 16098225 (Pubitemid 41243204)
34. Genetic analysis of Mulao nationality using 15 short tandem repeats. Xu L, Deng QY, Li SF, Zhou LN, Gong JC, Wei BY, Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2008 25 96 100 18247316 (Pubitemid 351796760)
35. Association of the GALNT2 gene polymorphisms and several environmental factors with serum lipid levels in the Mulao and Han populations. Li Q, Yin RX, Yan TT, Miao L, Cao XL, Hu XJ, Aung LH, Wu DF, Wu JZ, Lin WX, Lipids Health Dis 2011 10 160 10.1186/1476-511X-10-160 21933382
36. Association of the TRIB1 tribbles homolog 1 gene rs17321515 A≥G polymorphism and serum lipid levels in the Mulao and Han populations. Aung LH, Yin RX, Wu DF, Li Q, Yan TT, Wang YM, Li H, Wei DX, Shi YL, Yang DZ, Lipids Health Dis 2001 10 230
37. Sex-specific association of rs16996148 SNP in the NCAN/CILP2/PBX4 and serum lipid levels in the Mulao and Han populations. Yan TT, Yin RX, Li Q, Huang P, Zeng XN, Huang KK, Aung LH, Wu DF, Liu CW, Pan SL, Lipids Health Dis 2011 10 248 10.1186/1476-511X-10-248 22208664
38. An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the Peoples Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study. Peoples Republic of China-United States Cardiovascular and Cardiopulmonary Epidemiology Research Group, Circulation 1992 85 1083 1096 1537106
39. Comparison of six nucleic acid extraction methods for detection of viral DNA or RNA sequences in four different non-serum specimen types. Kok T, Wati S, Bayly B, Devonshire-Gill D, Higgins G, J Clin Virol 2000 16 59 63 10.1016/S1386-6532(99)00066-9 10680742 (Pubitemid 30066483)
40. Effect of the MTP-493G/T polymorphism on the lipid profiles of the Guangxi Hei Yi Zhuang and Han populations. Ruixing Y, Rongshan L, Weixiong L, Dezhai Y, Shangling P, Eur J Lipid Sci Technol 2006 108 561 568 10.1002/ejlt.200500281 (Pubitemid 44146208)
41. Association of the LIPG 584C≥T polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations. Liu WY, Yin RX, Zhang L, Cao XL, Miao L, Wu DF, Aung LH, Hu XJ, Lin WX, Yang DZ, Lipids Health Dis 2010 9 110 10.1186/1476-511X-9-110 20923576
42. Association of methylenetetrahydrofolate reductase C677T polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations. Zhang L, Yin RX, Liu WY, Miao L, Wu DF, Aung LH, Hu XJ, Cao XL, Wu JZ, Pan SL, Lipids Health Dis 2010 9 123 10.1186/1476-511X-9-123 20977771
43. Effects of demographic, dietary and other lifestyle factors on the prevalence of hyperlipidemia in Guangxi Hei Yi Zhuang and Han populations. Ruixing Y, Yuming C, Shangling P, Fengping H, Tangwei L, Dezhai Y, Jinzhen W, Limei Y, Weixiong L, Rongshan L, Jiandong H, Eur J Cardiovasc Prev Rehabil 2006 13 977 984 10.1097/01.hjr.0000239476.79428.25 17143131 (Pubitemid 44901161)
44. Comparison of demography, diet, lifestyle, and serum lipid levels between the Guangxi Mulao and Han populations. Ruixing Y, Qiming F, Dezhai Y, Shuquan L, Weixiong L, Shangling P, Hai W, Yongzhong Y, Feng H, Shuming Q, J Lipid Res 2007 48 2673 2681 10.1194/jlr.M700335-JLR200 17890682 (Pubitemid 350272852)
45. Diet, lifestyle, and blood pressure of the middle-aged and elderly in the Guangxi Bai Ku Yao and Han populations. Ruixing Y, Weixiong L, Hanjun Y, Dezhai Y, Shuquan L, Shangling P, Qiming F, Jinzhen W, Jianting G, Yaju D, Am J Hypertens 2008 21 382 387 10.1038/ajh.2008.1 18369357 (Pubitemid 351450865)
46. Comparison of hypertension and its risk factors between the Guangxi Bai Ku Yao and Han populations. Ruixing Y, Shangling P, Shuquan L, Dezhai Y, Weixiong L, Qiming F, Yuming C, Yaoheng H, Yijiang Z, Qinchen L, Blood Press 2008 17 306 316 10.1080/08037050802589593 19043819
47. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Cooperative Meta-analysis Group of China Obesity Task Force, Zhonghua Liu Xing Bing Xue Za Zhi 2002 23 5 10 12015100
48. Biological, clinical and population relevance of 95 loci for blood lipids. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, Johansen CT, Fouchier SW, Isaacs A, Peloso GM, Barbalic M, Ricketts SL, Bis JC, Aulchenko YS, Thorleifsson G, Feitosa MF, Chambers J, Orho-Melander M, Melander O, Johnson T, Li X, Guo X, Li M, Shin Cho Y, Jin Go M, Jin Kim Y, et al. Nature 2010 466 707 713 10.1038/nature09270 20686565
49. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. Mensink RP, Katan MB, N Engl J Med 1990 323 439 445 10.1056/NEJM199008163230703 2374566 (Pubitemid 20231555)
50. Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Judd JT, Clevidence BA, Muesing RA, Wittes J, Sunkin ME, Podczasy JJ, Am J Clin Nutr 1994 59 861 868 8147331 (Pubitemid 24112524)
51. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Trumbo P, Schlicker S, Yates AA, Poos M, J Am Diet Assoc 2002 102 1621 1630 10.1016/S0002-8223(02)90346-9 12449285 (Pubitemid 40434081)
52. Trans fatty acids and cardiovascular disease. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC, N Engl J Med 2006 354 1601 1613 10.1056/NEJMra054035 16611951
53. Trans fatty acids and coronary heart disease. Zaloga GP, Harvey KA, Stillwell W, Siddiqui R, Nutr Clin Pract 2006 21 505 512 10.1177/ 0115426506021005505 16998148 (Pubitemid 44497061)
54. Light-to-moderate alcohol consumption and mortality in the Physicians Health Study enrollment cohort. Gaziano JM, Gaziano TA, Glynn RJ, Sesso HD, Ajani UA, Stampfer MJ, Manson JE, Hennekens CH, Buring JE, J Am Coll Cardiol 2000 35 96 105 10.1016/S0735-1097(99)00531-8 10636266 (Pubitemid 30061266)
55. Effects of ethanol intake on lipoproteins and atherosclerosis. Brinton EA, Curr Opin Lipidol 2010 21 346 351 10.1097/MOL.0b013e32833c1f41 20616714
56. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA, Stampfer MJ, Willett WC, Rimm EB, N Engl J Med 2003 348 109 118 10.1056/NEJMoa022095 12519921 (Pubitemid 36056717)
57. Alcohol consumption and cardiovascular risk factors in older lifelong wine drinkers: The Italian Longitudinal Study on Aging. Perissinotto E, Buja A, Maggi S, Enzi G, Manzato E, Scafato E, Mastrangelo G, Frigo AC, Coin A, Crepaldi G, Sergi G, ILSA Working Group, Nutr Metab Cardiovasc Dis 2010 20 647 655 10.1016/j.numecd.2009.05.014 19695851
58. Associations of alcohol consumption with blood pressure, lipoproteins, and subclinical inflammation among Turks. Onat A, Hergenc G, Dursunoglu D, Ordu S, Can G, Bulur S, Yüksel H, Alcohol 2008 42 593 601 10.1016/j.alcohol. 2008.06.007 18835594
59. Alcohol consumption and the risk of hypertension in women and men. Sesso HD, Cook NR, Buring JE, Manson JE, Gaziano JM, Hypertension 2008 51 1080 1087 10.1161/HYPERTENSIONAHA.107.104968 18259032 (Pubitemid 351398961)
60. Association between alcohol intake amount and prevalence of metabolic syndrome in Korean rural male population. Lee MY, Kim MY, Kim SY, Kim JH, Kim BH, Shin JY, Shin YG, Yun JH, Ryu SY, Lee TY, Koh SB, Chung CH, Diabetes Res Clin Pract 2010 88 196 202 10.1016/j.diabres.2010.01.009 20189260
61. Genes, diet and serum lipid concentrations: lessons from ethnically diverse populations and their relevance to coronary heart disease in Asia. Tai ES, Tan CE, Curr Opin Lipidol 2004 15 5 12 10.1097/00041433-200402000-00003 15166802 (Pubitemid 39118011)
62. HDL genetics: candidate genes, genome wide scans and gene-environment interactions. Ordovas JM, Cardiovasc Drugs Ther 2002 16 273 281 10.1023/A:1021769523568 12652095 (Pubitemid 36174163)